Global In-Vivo Imaging Market Size To Exceed USD 5.54 Billion By 2035 | CAGR of 5.12%
Category: HealthcareGlobal In-Vivo Imaging Market Size To Exceed USD 5.54 Billion By 2035
According to a research report published by Spherical Insights & Consulting, The Global In-Vivo Imaging Market Size is expected to grow from USD 3.20 Billion in 2024 to USD 5.54 Billion by 2035, at a CAGR of 5.12% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global In-Vivo Imaging Market Size, Share, and COVID-19 Impact Analysis, By Technology (Magnetic Resonance Imaging, Digital Angiography, Ultrasound, Nuclear Imaging, and Others), By Application (Monitoring Drug Treatment Response, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, and Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, and Contract Research Organizations (CROs)), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. " Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/in-vivo-imaging-market
The in-vivo imaging market refers to the technologies and systems for non-invasively visualizing and studying biological processes within living organisms, primarily for drug development, disease research, and clinical diagnostics. In vivo imaging aids in observing anatomical structures, molecular/cellular activities, and metabolic functions as they occur more naturally within whole organisms. There is an increasing demand for in vivo imaging, with molecular imaging experiencing increased use as a companion diagnostic with an increasing prioritization towards precision medicine. An increasing technological development in the in-vivo imaging system, along with advancements in healthcare services and technology, is driving the in-vivo imaging market. Further, the growing prevalence of chronic diseases is anticipated to drive the demand for in-vivo imaging owing to its widespread application in drug development. On the contrary, the high implementation cost of sophisticated imaging systems, stringent regulations, and lack of skilled professionals are challenging the market growth.
The magnetic resonance imaging segment dominated the market with the largest share of 26.7% in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the technology, the in-vivo imaging market is divided into magnetic resonance imaging, digital angiography, ultrasound, nuclear imaging, and others. Among these, the magnetic resonance imaging segment dominated the market with the largest share of 26.7% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Magnetic resonance imaging is used to noninvasively observe and monitor biological processes within living organisms, like detecting phagocytic cell activity in neuroinflammatory diseases, enhancing imaging sensitivity and providing insights into cellular behavior. The capacity of MRI to deliver high contrast images for repeated imaging in clinical and research settings is driving the market.
The monitoring drug treatment response segment accounted for the dominant market share of 33.5% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the in-vivo imaging market is divided into monitoring drug treatment response, bio distribution studies, cancer cell detection, biomarkers, and others. Among these, the monitoring drug treatment response segment accounted for the dominant market share of 33.5% in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. In vivo imaging in preclinical studies is impacting drug development via monitoring disease progression and therapeutic response. The growing demand for dynamic evaluation of therapeutic interventions in real time is driving the market demand in the monitoring drug treatment response segment.
The pharmaceutical & biotechnology companies segment accounted for the largest share of 48.5% in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end user, the in-vivo imaging market is divided into pharmaceutical & biotechnology companies, academic & research institutions, and contract research organizations (CROs). Among these, the pharmaceutical & biotechnology companies segment accounted for the largest share of 48.5% in 2024 and is anticipated to grow at a significant CAGR during the forecast period. In vivo imaging is used for optimization of lead selection and accelerating preclinical validation. The pharmaceutical industry’s growing emphasis on efficient drug development, along with an increasing collaboration between academic institutions, pharmaceutical companies, and imaging technology providers, is promoting the market growth.
North America is expected to hold the majority share of the global in-vivo imaging market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global in-vivo imaging market during the forecast period. The demand for in-vivo imaging has been driven by the government-funded initiatives, expansion of contract research organisations & collaborative research. Further, the presence of biotech and pharma organizations, federal research funding, and strong supply chain administration are contributing to regional market growth. Continuous innovation in imaging technologies, drug development & cancer research is promoting the in-vivo imaging market.
Asia Pacific is anticipated to grow at the fastest pace in the global in-vivo imaging market during the forecast period. Increasing investments and funds by key players and governments in countries such as India and China are driving the growth of small animal imaging, contributing to the growth of the in-vivo imaging market. With an increasing demand for affordable treatment options, multinational companies are investing more in the development of in-vivo imaging across developing economies such as India and China.
Major vendors in the global in-vivo imaging market are PerkinElmer Inc., Bruker, FUJIFILM Holdings America Corporation, Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso Ltd., LI-COR, Inc., Takara Bio Inc., MILabs B.V., MR Solutions, Trifoil Imaging, Biospace Lab, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2025, Revvity, Inc., announced the launch of its Living Image Synergy AI multimodal analysis software for in vivo imaging researchers. The solution provides a unified platform with AI capabilities for seamless data analysis across optical, microCT, ultrasound, and other modalities, reducing data inconsistencies, streamlining workflows, increasing throughput, and enhancing reproducibility, all with the intention of accelerating scientific discovery.
- In August 2023, SSM Health and Siemens Healthineers partnered to advance health equity and empower workforce development in underserved communities. Through a shared dedication to clinical and operational excellence, the partners would further enhance quality, efficiency, and access to diagnostic and imaging services for communities across SSM Health’s four-state service area, which includes Illinois, Missouri, Oklahoma, and Wisconsin.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the in-vivo imaging market based on the below-mentioned segments:
Global In-Vivo Imaging Market, By Technology
- Magnetic Resonance Imaging
- Digital Angiography
- Ultrasound
- Nuclear Imaging
- Others
Global In-Vivo Imaging Market, By Application
- Monitoring Drug Treatment Response
- Bio Distribution Studies
- Cancer Cell Detection
- Biomarkers
- Others
Global In-Vivo Imaging Market, By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutions
- Contract Research Organizations (CROs)
Global In-Vivo Imaging Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?